Patents
Patents for C07C 275 - Derivatives of urea, i.e. compounds containing any of the groups the nitrogen atoms not being part of nitro or nitroso groups (9,848)
04/2006
04/25/2006US7034182 Compounds to treat Alzheimer's disease
04/25/2006US7034056 Aryl and biaryl compounds having MCH modulatory activity
04/25/2006US7034015 Interleukin 1 beta and tumour necrosis factor alpha inhibitors
04/25/2006US7033522 Reacting a polyisocyanate with a hydrophilicizing component; reacting free isocyanate groups with a blocking agents, and optionally neutralizing; curing agents for polyurethane and acrylic dispersions.
04/21/2006CA2523907A1 Buretized isocyanates and blocked biuretized isocyanates
04/21/2006CA2523905A1 Blocked biuretized isocyanates
04/21/2006CA2523840A1 Blocked biuretized isocyanates
04/20/2006WO2006041841A1 Phenyl derivatives and methods of use
04/20/2006WO2006040625A1 Novel dipeptidyl peptidase iv inhibitors, pharmaceutical compositions containing them, and process for their preparation
04/20/2006CA2583457A1 Novel dipeptidyl peptidase iv inhibitors, pharmaceutical compositions containing them, and process for their preparation
04/20/2006CA2583297A1 Phenyl derivatives and methods of use
04/20/2006CA2523401A1 Crystallization-stable mdi allophanates by a two-stage process
04/19/2006CN1761653A Processes for the preparation of N-heteroaryl-N-aryl-amines by reacting an N-aryl carbamic acid ester with a halo-heteroaryl and analogous processes
04/19/2006CN1252038C New derivatives of substituted anilines with herbicidal activity
04/18/2006US7030261 reacting 2-hydroxy-6-aminocarbonyl naphthalene and an isocyanate in an organic solvent at a temperature of 90-200 degrees C.; high speed, high yields
04/18/2006US7030214 Ureins derived from α, ω, diamino acids and process for their preparation
04/13/2006WO2006038606A1 Biaryl derivative
04/13/2006WO2006037574A1 Improved synthesis scheme for lacosamide
04/13/2006WO2006037468A1 Hiv reverse transcriptase inhibitors
04/13/2006WO2005007621A3 Ubiquitin ligase inhibitors
04/13/2006CA2570598A1 Improved synthesis scheme for lacosamide
04/12/2006EP1644341A1 Process of making di-aryl urea compounds
04/12/2006EP1644323A2 Histone deacetylase inhibitors and methods of use thereof
04/12/2006EP1005356B1 Novel antibacterial agents
04/11/2006US7026357 Diphenylurea compounds
04/11/2006US7026297 Neuroprotective agents
04/11/2006CA2155013C C2 taxane derivatives and pharmaceutical compositions containing them
04/06/2006US20060074110 Multicyclic compounds which inhibit leukocyte adhesion mediated by VLA-4
04/06/2006DE102004047921A1 Polyisocyanate mit sterisch anspruchsvollen Phenolen blockiert Blocked polyisocyanates with bulky phenols
04/05/2006EP1642889A1 Improved synthesis scheme for lacosamide
04/05/2006EP1642888A1 compounds for modulating the rage receptor
04/05/2006EP1641746A2 Polyurea polymers from secondary polyether polyamines
04/05/2006EP1641745A1 Propionamide derivatives useful as androgen receptor modulators
04/05/2006EP1453777B1 Functionalized higher diamondoids
04/05/2006CN1249025C Aminobenzophenones as inhibiotors of IL-1 beta and TNF-alpha
04/05/2006CN1249020C Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof
04/04/2006US7022874 Preparation of biuret-containing polyisocyanates
04/04/2006US7022648 Plant growth regulators; reactin gformic acid with urea
04/04/2006CA2187222C Method of preparing a carbamate-or urea-functional compound
03/2006
03/30/2006US20060069255 Novel aryl ureido benzoic acid derivatives and their use
03/30/2006US20060069154 Enzyme activated self-immolative n-substituted nitrogen mustard prodrugs
03/29/2006EP1640361A2 Asymmetric urea compound and process for producing asymmetric compound by asymmetric conjugate addition reaction with the same as catalyst
03/29/2006EP1200395B1 Urea derivatives as inhibitors of ccr-3 receptor
03/29/2006CN1753866A Arylcycloalkyl derivatives having branched side chains used as ppar receptor regulator, processes for their preparation and their use as pharmaceuticals
03/29/2006CN1753865A Cycloalkyl-substituted alkanoic acid derivatives, processes for their preparation and their use as pharmaceuticals
03/29/2006CN1247528C Novel tricyclic compounds, preparation method and pharmaceutical compositions containing same
03/29/2006CN1247511C Tropolone derivative
03/28/2006CA2153805C C10 taxane derivatives and pharmaceutical compositions
03/23/2006US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease
03/23/2006US20060062726 with iodophenyl group (radioisotope), as a membrane component of liposomes, which enables lesion-selective contrast X-ray radiography of a vascular disease; metabolized in the liver, not accumulated in living bodies
03/22/2006EP1140840B1 -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
03/22/2006CN1246287C Binaphthol derivative and method for producing same
03/21/2006US7015345 Propionic acid derivatives
03/21/2006CA2267251C Novel phenoxyethylamine derivatives, method of preparation, application as medicine and pharmaceutical compositions containing same
03/21/2006CA2072416C Cyclopropenone derivatives
03/16/2006US20060058553 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
03/16/2006US20060058396 Amide compounds for the potentiation of cholinergic activity
03/16/2006US20060058298 Inhibitors of histone deacetylase
03/16/2006US20060057194 introducing a biologically active agent into a cell of a plant or animal comprising: contacting said cell with lipid vesicles comprising amino acid amide lipids in vivo or in vitro; gene therapy
03/16/2006DE102004043538A1 Herstellung von neuen strahlenhärtenden Bindemitteln Production of new radiation-curing binders
03/15/2006EP1499645B1 Incorporable photoinitiator
03/15/2006CN1747926A Substituted amides
03/15/2006CN1245394C Substituted phenylacetamides and their use as glucokinase activators
03/15/2006CN1245380C Anthranilic acid derivatives
03/09/2006WO2005122379A9 Alpha-4 beta-1 integrin ligands for imaging and therapy
03/09/2006WO2004089296A3 Improved inhibitors for the soluble epoxide hydrolase
03/09/2006CA2518141A1 Low viscosity allophanates containing actinically curable groups
03/09/2006CA2518139A1 Radiation-curing binders and process for their preparation
03/09/2006CA2518137A1 Low viscosity allophanates containing actinically curable groups
03/09/2006CA2518135A1 Radiation-curing binders and a process for their preparation
03/08/2006EP1039902B1 Inhibitors of gap junction communication
03/08/2006CN1244569C C-10 position taxane derivative and its medicine composition
03/08/2006CN1244553C Preparing method for inactive nitric acid powder
03/02/2006WO2006023457A1 COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY
03/01/2006EP1628952A1 Ionic liquid comprising uronium cations or thiouronium cations
03/01/2006CN1741986A Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
03/01/2006CN1740181A New pirkle-type chiral fixed phase and its prepn process
03/01/2006CN1740140A Urea process of synthesizing tert-butyl amine with tert-butyl alcohol
03/01/2006CN1243728C Novel color-developing compound and recording material
02/2006
02/28/2006CA2331877C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
02/23/2006WO2006018326A1 Novel biaromatic compounds that activate ppar type receptors, and use thereof in cosmetic or pharmaceutical compositions
02/23/2006US20060041014 Treatment of male sexual dysfunction
02/23/2006US20060040979 3-Aryl-2-hydroxypropionic acid derivative I
02/23/2006CA2575033A1 Novel biaromatic compounds that activate ppar type receptors, and use thereof in cosmetic or pharmaceutical compositions
02/22/2006CN1736983A N-phenyl formamide-acrylamide and its synthesis method
02/21/2006US7002042 Cationic liposomes for gene transfer
02/16/2006WO2006015852A1 Organic compounds
02/16/2006WO2005058798A3 Compounds having selective cytochrome p450rai-1 or selective cytochrome p450rai-2 inhibitory activity and methods of obtaining the same
02/16/2006WO2004101752A3 Compounds for treatment of inflammation, diabetes and related disorders
02/16/2006CA2574914A1 Organic compounds
02/15/2006EP1625207A2 Compounds for treatment of inflammation, diabetes and related disorders
02/15/2006CN1241916C Novel acardite compound, its preparation method and medicinal composition containing said compound
02/14/2006CA2248598C Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
02/09/2006US20060030553 Cell adhesion inhibitors
02/08/2006EP1406865B1 Succinic acid derivatives
02/07/2006US6995285 ABCA-1 elevating compounds
02/02/2006WO2006010362A1 Amino adamantane derivatives, methods for the production and use thereof
02/02/2006WO2005113511A9 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
02/01/2006EP1620393A1 Process for the preparation of a urea and formaldehyde-containing aqueous solution
02/01/2006EP1463707A4 A group of novel anti-cancer compounds with specific structure
1 ... 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 ... 99